Vaccines have had a major impact on the control of infectious disease, most recently by helping to combat the COVID-19 pandemic. Prophylactic cancer vaccines have prevented several malignancies by ...

A research team led by Prof. Li Hai from the Hefei Institutes of Physical Science of the Chinese Academy of Sciences has ...

Mike Dovidio says adding scanning power can make drug spending more efficient — and save some patients' lives.

The partners have committed to awarding two grants, totaling around $2.3 million, to researchers studying this lung cancer subset.

The results suggest toxicity may not be as pervasive as previously thought, which argues for more-personalized monitoring.

Dr. Sara M. Tolaney breaks down key takeaways from the DESTINY-Breast09 trial that patients with HER2+ advanced or metastatic ...

New Team Science Award is $1.5 million Over Three Years NEW YORK, June 17, 2025 /PRNewswire/ -- The Lung Cancer Research Foundation (LCRF) announces today ...

Million Research Collaboration Focused on Understanding and Treating Lung Cancers Harboring HER2 Mutations; call for Requests for Proposals NEW ...

Both non-small lung cancer and small cell lung cancer is a disease that now has various therapeutic options available, ...

Scientists uncover surprising immune response that helps tumors grow, revealing new strategies to improve treatment ...

Studies presented at the ASCO Annual Meeting 2025 highlighted immunotherapies that may provide new standards of care for certain cancers as well as immunotherapies that are breaking new ground by ...

Atezolizumab did not confer any benefits when added to SBRT in a phase 3 trial of patients with inoperable, early-stage NSCLC.